Paper36727232
[MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23].
Liu XL and 4 others. Zhonghua Gan Zang Bing Za Zhi, 2022. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. [MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23]. Papers, record 36727232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36727232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23].
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| MicroRNAs | Major topic |
| Microtubule-Associated Proteins | Major topic |
| Humans | |
| Cell Movement | |
| Cell Proliferation | |
| Family | |
| Gene Expression Regulation, Neoplastic | |
| Kinesins | |
| Sorafenib | |
| Hep G2 Cells |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2018KZ0049 | Science and Technology Project of Sichuan | PubMed |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32832397 | Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options. | J Clin Transl Hepatol | 2020 | https://conductscience.org/library/papers/32832397 | PubMed |
| 2 | 32520206 | MicroRNA-424-5p inhibits the proliferation, migration, and invasion of nasopharyngeal carcinoma cells by decreasing AKT3 expression. | Braz J Med Biol Res | 2020 | https://conductscience.org/library/papers/32520206 | PubMed |
| 3 | 33313139 | KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target. | Ann Transl Med | 2020 | https://conductscience.org/library/papers/33313139 | PubMed |
| 4 | 34014023 | MiR-17-5p downregulation alleviates apoptosis and fibrosis in high glucose-induced human mesangial cells through inactivation of Wnt/β-catenin signaling by targeting KIF23. | Environ Toxicol | 2021 | https://conductscience.org/library/papers/34014023 | PubMed |
| 5 | 34107580 | [Effect of miR-23b on the malignant phenotype and the sensitivity of lenvatinib in human hepatocellular carcinoma cells]. | Zhonghua Gan Zang Bing Za Zhi | 2021 | https://conductscience.org/library/papers/34107580 | PubMed |
| 6 | 34966644 | MicroRNA-7-5p Inhibits Migration, Invasion and Metastasis of Intrahepatic Cholangiocarcinoma by Inhibiting MyD88. | J Clin Transl Hepatol | 2021 | https://conductscience.org/library/papers/34966644 | PubMed |
| 7 | 34268078 | KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition. | Gland Surg | 2021 | https://conductscience.org/library/papers/34268078 | PubMed |
| 8 | 31135262 | Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23. | Cell Cycle | 2019 | https://conductscience.org/library/papers/31135262 | PubMed |
| 9 | 31360102 | miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5. | Int J Biol Sci | 2019 | https://conductscience.org/library/papers/31360102 | PubMed |
| 10 | 31594104 | [Advances in the study of programmed cell death protein 1 and its ligand inhibitors in the treatment of late stage HCC]. | Zhonghua Gan Zang Bing Za Zhi | 2019 | https://conductscience.org/library/papers/31594104 | PubMed |
| 11 | 31007778 | KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation. | Dis Markers | 2019 | https://conductscience.org/library/papers/31007778 | PubMed |
| 12 | 34722189 | Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. | J Clin Transl Hepatol | 2021 | https://conductscience.org/library/papers/34722189 | PubMed |
| 13 | 32138313 | Regulatory Mechanism of MicroRNA Expression in Cancer. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32138313 | PubMed |
| 14 | 34381736 | Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4. | Front Oncol | 2021 | https://conductscience.org/library/papers/34381736 | PubMed |
| 15 | 33754001 | Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer. | J Cancer | 2021 | https://conductscience.org/library/papers/33754001 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42410612 | KIF23 in disease pathogenesis and therapeutics : from molecular mechanisms to clinical translation. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42410612 | PubMed |
| 42178466 | KIF23 in disease pathogenesis and its therapeutic and diagnostic potential. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42178466 | PubMed |
| 38433242 | The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside. | Biomark Res | 2024 | https://conductscience.org/library/papers/38433242 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KIF23 | 9493 | PubTator's text mining | https://conductscience.org/library/genes/9493 | NCBI Gene |
| MIR424 | 494336 | PubTator's text mining | https://conductscience.org/library/genes/494336 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36727232
GET https://conductscience.org/api/papers/v1/36727232/authors